Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?

Environmental contributions to cancer development are widely accepted, but only a fraction of all pertinent exposures have probably been identified. Traditional toxicological approaches to the problem have largely focused on the effects of individual agents at singular endpoints. As such, they have incompletely addressed both the pro-carcinogenic contributions of environmentally relevant low-dose chemical mixtures and the fact that exposures can influence multiple cancer-associated endpoints over varying timescales. Of these endpoints, dysregulated metabolism is one of the most common and recognizable features of cancer, but its specific roles in exposure-associated cancer development remain poorly understood. Most studies have focused on discrete aspects of cancer metabolism and have incompletely considered both its dynamic integrated nature and the complex controlling influences of substrate availability, external trophic signals and environmental conditions. Emerging high throughput approaches to environmental risk assessment also do not directly address the metabolic causes or consequences of changes in gene expression. As such, there is a compelling need to establish common or complementary frameworks for further exploration that experimentally and conceptually consider the gestalt of cancer metabolism and its causal relationships to both carcinogenesis and the development of other cancer hallmarks. A literature review to identify environmentally relevant exposures unambiguously linked to both cancer development and dysregulated metabolism suggests major gaps in our understanding of exposure-associated carcinogenesis and metabolic reprogramming. Although limited evidence exists to support primary causal roles for metabolism in carcinogenesis, the universality of altered cancer metabolism underscores its fundamental biological importance, and multiple pleiomorphic, even dichotomous, roles for metabolism in promoting, antagonizing or otherwise enabling the development and selection of cancer are suggested.

[1]  Anna C. Salzberg,et al.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead , 2015, Carcinogenesis.

[2]  Xiling Shen,et al.  Epigenetics and cancer metabolism. , 2015, Cancer letters.

[3]  Fei Zhao,et al.  Arsenite-Induced Pseudo-Hypoxia Results in Loss of Anchorage-Dependent Growth in BEAS-2B Pulmonary Epithelial Cells , 2014, PloS one.

[4]  D. Hardie AMP‐activated protein kinase: a key regulator of energy balance with many roles in human disease , 2014 .

[5]  S. McGuire,et al.  Centers for Disease Control and Prevention. State indicator report on Physical Activity, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. , 2014, Advances in nutrition.

[6]  William A. Flavahan,et al.  Cancer Stem Cell‐Specific Scavenger Receptor CD36 Drives Glioblastoma Progression , 2014, Stem cells.

[7]  T. Soga,et al.  Rare insights into cancer biology , 2014, Oncogene.

[8]  J. Hinchion,et al.  Releasing pressure in tumors: what do we know so far and where do we go from here? A review. , 2014, Cancer research.

[9]  J. Bunkenborg,et al.  S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells , 2014, Nature Communications.

[10]  Liewei Wang,et al.  AMPK regulates histone H2B O-GlcNAcylation , 2014, Nucleic acids research.

[11]  J. Bolaños TIGAR's promiscuity. , 2014, The Biochemical journal.

[12]  I. Gérin,et al.  Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase. , 2014, The Biochemical journal.

[13]  Jeffry D. Sander,et al.  CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.

[14]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[15]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[16]  K. Ramana,et al.  Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells. , 2013, Free radical biology & medicine.

[17]  R. Mostoslavsky,et al.  The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease. , 2013, Current topics in medicinal chemistry.

[18]  Yi-Jun Wu,et al.  A metabonomic investigation of the effects of 60 days exposure of rats to two types of pyrethroid insecticides. , 2013, Chemico-biological interactions.

[19]  F. Giancotti Mechanisms Governing Metastatic Dormancy and Reactivation , 2013, Cell.

[20]  K. Vousden,et al.  Metabolic Regulation by p53 Family Members , 2013, Cell metabolism.

[21]  J. Deitmer,et al.  Transport metabolons with carbonic anhydrases , 2013, Front. Physiol..

[22]  Melinda M. Mulvihill,et al.  Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. , 2013, Biochimica et biophysica acta.

[23]  J. Swinnen,et al.  Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. , 2013, Progress in lipid research.

[24]  John M Denu,et al.  Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins* ♦ , 2013, The Journal of Biological Chemistry.

[25]  G. Semenza,et al.  HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. , 2013, The Journal of clinical investigation.

[26]  Ralph J DeBerardinis,et al.  Glutamine and cancer: cell biology, physiology, and clinical opportunities. , 2013, The Journal of clinical investigation.

[27]  Fei Zhao,et al.  Arsenic exposure induces the Warburg effect in cultured human cells. , 2013, Toxicology and applied pharmacology.

[28]  Abhishek K. Jha,et al.  Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. , 2013, Cancer cell.

[29]  D. Straus TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells , 2013, Molecular Cancer.

[30]  K. Vosseller,et al.  O-GlcNAc in cancer biology , 2013, Amino Acids.

[31]  J. Locasale Serine, glycine and one-carbon units: cancer metabolism in full circle , 2013, Nature Reviews Cancer.

[32]  Linghua Wang,et al.  From human genome to cancer genome: The first decade , 2013, Genome research.

[33]  T. Mak,et al.  Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. , 2013, Cancer discovery.

[34]  C. López-Otín,et al.  Supercomplex Assembly Determines Electron Flux in the Mitochondrial Electron Transport Chain , 2013, Science.

[35]  L. O’Neill,et al.  How Metabolism Generates Signals during Innate Immunity and Inflammation* , 2013, The Journal of Biological Chemistry.

[36]  Douglas Strathdee,et al.  TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis , 2013, Developmental cell.

[37]  M. Ohmura,et al.  Energy Management by Enhanced Glycolysis in G1-phase in Human Colon Cancer Cells In Vitro and In Vivo , 2013, Molecular Cancer Research.

[38]  Min-Dian Li,et al.  Cracking the O-GlcNAc code in metabolism , 2013, Trends in Endocrinology & Metabolism.

[39]  David I Heiman,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2013, Nature.

[40]  C. Brisken,et al.  Does Cancer Start in the Womb? Altered Mammary Gland Development and Predisposition to Breast Cancer due to in Utero Exposure to Endocrine Disruptors , 2013, Journal of Mammary Gland Biology and Neoplasia.

[41]  G. Mills,et al.  AMPK: a contextual oncogene or tumor suppressor? , 2013, Cancer research.

[42]  E. White,et al.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.

[43]  Hai Yan,et al.  Releasing the block: setting differentiation free with mutant IDH inhibitors. , 2013, Cancer cell.

[44]  Fang Wang,et al.  An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells , 2013, Science.

[45]  W. Kuo,et al.  Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells , 2013, Cell Death and Disease.

[46]  O. Leo,et al.  Sirtuin deacylases: a molecular link between metabolism and immunity , 2013, Journal of leukocyte biology.

[47]  Michael O. Hengartner,et al.  Mitochondria as a Target of Environmental Toxicants , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  M. Kilberg,et al.  Asparagine synthetase: regulation by cell stress and involvement in tumor biology. , 2013, American journal of physiology. Endocrinology and metabolism.

[49]  W. Kaelin,et al.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. , 2013, Genes & development.

[50]  D. Vitkup,et al.  Heterogeneity of tumor-induced gene expression changes in the human metabolic network , 2013, Nature Biotechnology.

[51]  L. Szablewski Expression of glucose transporters in cancers. , 2013, Biochimica et biophysica acta.

[52]  K. Adeli,et al.  Autophagy: Emerging roles in lipid homeostasis and metabolic control. , 2013, Biochimica et biophysica acta.

[53]  D. Hardie,et al.  AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells? , 2013, Biochemical Society transactions.

[54]  R. Sturmey,et al.  Parallels between embryo and cancer cell metabolism. , 2013, Biochemical Society transactions.

[55]  I. Minko,et al.  Translesion Synthesis Past Acrolein-derived DNA Adducts by Human Mitochondrial DNA Polymerase γ* , 2013, The Journal of Biological Chemistry.

[56]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[57]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[58]  M. Bonner,et al.  Increased cancer burden among pesticide applicators and others due to pesticide exposure , 2013, CA: a cancer journal for clinicians.

[59]  T. Yagi,et al.  Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. , 2013, The Journal of clinical investigation.

[60]  S. Young,et al.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis. , 2013, Genes & development.

[61]  M. V. Vander Heiden,et al.  Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States , 2013, Science Signaling.

[62]  R. Tomasini,et al.  Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[63]  S. Kornbluth,et al.  The tangled circuitry of metabolism and apoptosis. , 2013, Molecular cell.

[64]  L. Moore,et al.  Drinking Water Arsenic in Northern Chile: High Cancer Risks 40 Years after Exposure Cessation , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[65]  M. Martin,et al.  Metals and Breast Cancer , 2013, Journal of Mammary Gland Biology and Neoplasia.

[66]  K. Vousden,et al.  p53 mutations in cancer , 2013, Nature Cell Biology.

[67]  Michael D. Henry,et al.  Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells , 2012, PloS one.

[68]  K. Vousden,et al.  Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death , 2012, Proceedings of the National Academy of Sciences.

[69]  Jared L. Johnson,et al.  Interactions between epigenetics and metabolism in cancers , 2012, Front. Oncol..

[70]  R. Deberardinis,et al.  Genetically-defined metabolic reprogramming in cancer , 2012, Trends in Endocrinology & Metabolism.

[71]  G. Semenza,et al.  Emerging roles of PKM2 in cell metabolism and cancer progression , 2012, Trends in Endocrinology & Metabolism.

[72]  R. LoPachin,et al.  Molecular Mechanism of Acrylamide Neurotoxicity: Lessons Learned from Organic Chemistry , 2012, Environmental health perspectives.

[73]  L. Alberghina,et al.  Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling , 2012, Front. Physio..

[74]  S. Coster,et al.  Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action , 2012 .

[75]  J. Dumont,et al.  Hallmarks of cancer: of all cancer cells, all the time? , 2012, Trends in molecular medicine.

[76]  D. Sabatini,et al.  Cancer cell metabolism: one hallmark, many faces. , 2012, Cancer discovery.

[77]  Xianglin Shi,et al.  Oxidative stress and metal carcinogenesis. , 2012, Free radical biology & medicine.

[78]  E. Gottlieb,et al.  Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. , 2012, Trends in biochemical sciences.

[79]  M. Notarnicola,et al.  A significant role of lipogenic enzymes in colorectal cancer. , 2012, Anticancer research.

[80]  S. Copley Moonlighting is mainstream: Paradigm adjustment required , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[81]  C. Thornton,et al.  AMP-activated protein kinase: new regulation, new roles? , 2012, The Biochemical journal.

[82]  Nolan G. Ericson,et al.  Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer , 2012, PLoS genetics.

[83]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[84]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[85]  K. Ryan,et al.  Autophagy and cancer – issues we need to digest , 2012, Journal of Cell Science.

[86]  Luciano Galdieri,et al.  Acetyl-CoA Carboxylase Regulates Global Histone Acetylation*♦ , 2012, The Journal of Biological Chemistry.

[87]  Richard W. Hanson,et al.  Resurgence of Serine: An Often Neglected but Indispensable Amino Acid* , 2012, The Journal of Biological Chemistry.

[88]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[89]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[90]  A. Cuervo,et al.  Lipophagy: Connecting Autophagy and Lipid Metabolism , 2012, International journal of cell biology.

[91]  G. Colditz,et al.  Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. , 2012, Annual review of public health.

[92]  Laura N. Vandenberg,et al.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.

[93]  Xueliang Gao,et al.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. , 2012, Molecular cell.

[94]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[95]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[96]  B. Ramsahoye,et al.  Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression , 2012, Nucleic acids research.

[97]  B. Han,et al.  Identification of mammary epithelial cells subject to chronic oxidative stress in mammary epithelium of young women and teenagers living in USA , 2012, Cancer biology & therapy.

[98]  A. Lane,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[99]  K. Khalili,et al.  Oncogenic Viruses and Tumor Glucose Metabolism: Like Kids in a Candy Store , 2012, Molecular Cancer Therapeutics.

[100]  M. Kruszewski,et al.  Biomonitoring and biomarkers of organophosphate pesticides exposure - state of the art. , 2011, Annals of agricultural and environmental medicine : AAEM.

[101]  T. Mak,et al.  ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. , 2011, Molecular cell.

[102]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[103]  Jason W Locasale,et al.  Metabolic flux and the regulation of mammalian cell growth. , 2011, Cell metabolism.

[104]  Jason H. Moore,et al.  Layers of epistasis: genome‐wide regulatory networks and network approaches to genome‐wide association studies , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[105]  Abhishek K. Jha,et al.  Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011, Nature.

[106]  J. Boyd,et al.  Exploring the boundaries of additivity: mixtures of NADH: quinone oxidoreductase inhibitors. , 2011, Chemical research in toxicology.

[107]  Christian M. Metallo,et al.  Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics. , 2011, Current pharmaceutical biotechnology.

[108]  Z. Derdák,et al.  Mitochondrial recoupling: a novel therapeutic strategy for cancer? , 2011, British Journal of Cancer.

[109]  Matthew K. Knabel,et al.  Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 , 2011, Cell.

[110]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[111]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[112]  B. Eisenberg,et al.  Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation , 2011, Molecular Cancer Therapeutics.

[113]  H. Coller,et al.  The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.

[114]  Patries M Herst,et al.  Metabolic flexibility and cell hierarchy in metastatic cancer. , 2010, Mitochondrion.

[115]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[116]  Sebastian Munck,et al.  De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. , 2010, Cancer research.

[117]  David Carling,et al.  Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation , 2010, Science.

[118]  Jason W. Locasale,et al.  Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells , 2010, Science.

[119]  Douglas B. Kell,et al.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples , 2010, Archives of Toxicology.

[120]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[121]  Hai Yan,et al.  Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. , 2010, Journal of the National Cancer Institute.

[122]  P. Bernardi,et al.  Signal transduction to the permeability transition pore , 2010, FEBS letters.

[123]  Scott Weichenthal,et al.  A Review of Pesticide Exposure and Cancer Incidence in the Agricultural Health Study Cohort , 2010, Environmental health perspectives.

[124]  E. Campbell,et al.  Metabolic Shifts in Immunity and Inflammation , 2010, The Journal of Immunology.

[125]  M. Bonini,et al.  A mutant telomerase defective in nuclear‐cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction , 2010, Aging cell.

[126]  E. Morselli,et al.  Autophagy regulation by p53. , 2010, Current opinion in cell biology.

[127]  Yuri Lazebnik,et al.  What are the hallmarks of cancer? , 2010, Nature Reviews Cancer.

[128]  N. Tanaka,et al.  Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3. , 2010, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[129]  G. Brewer Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories , 2010, Experimental Gerontology.

[130]  Robert J Kavlock,et al.  Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. , 2010, Chemical research in toxicology.

[131]  L. Alberghina,et al.  Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. , 2010, Biochimica et biophysica acta.

[132]  R. Deberardinis,et al.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.

[133]  D. Wallace,et al.  Mitochondrial energetics and therapeutics. , 2010, Annual review of pathology.

[134]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[135]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[136]  J. Pouysségur,et al.  Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer , 2009, Journal of cellular and molecular medicine.

[137]  S. McMahon,et al.  Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells. , 2009, Trends in biochemical sciences.

[138]  Jin-Sung Choi,et al.  Evidence for a separate mechanism of toxicity for the Type I and the Type II pyrethroid insecticides. , 2009, Neurotoxicology.

[139]  J. Nadeau Transgenerational genetic effects on phenotypic variation and disease risk. , 2009, Human molecular genetics.

[140]  V. Graupner,et al.  The do's and don'ts of p53 isoforms , 2009, Biological chemistry.

[141]  Dianne Ford,et al.  Metalloproteins and metal sensing , 2009, Nature.

[142]  John Peterson Myers,et al.  A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.

[143]  David R Geter,et al.  Early alterations in protein and gene expression in rat kidney following bromate exposure. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[144]  A. Yalçin,et al.  Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. , 2009, Experimental and molecular pathology.

[145]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[146]  Z. Elazar,et al.  Lipophagy: selective catabolism designed for lipids. , 2009, Developmental cell.

[147]  R. Eckel,et al.  Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways Published, JLR Papers in Press, November 24, 2008. , 2009, Journal of Lipid Research.

[148]  M. Andreeff,et al.  Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. , 2009, Cancer research.

[149]  N. Hay,et al.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.

[150]  A. Starkov The Role of Mitochondria in Reactive Oxygen Species Metabolism and Signaling , 2008, Annals of the New York Academy of Sciences.

[151]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[152]  E. Levin,et al.  Exposure of Neonatal Rats to Parathion Elicits Sex-Selective Reprogramming of Metabolism and Alters the Response to a High-Fat Diet in Adulthood , 2008, Environmental health perspectives.

[153]  Sergei Romanov,et al.  Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors , 2008, Nature Methods.

[154]  S. Anderson,et al.  Sugar and fat – that's where it's at: metabolic changes in tumors , 2008, Breast Cancer Research.

[155]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[156]  K. Park,et al.  Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake , 2008, Journal of Molecular Medicine.

[157]  S. Moncada,et al.  Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[158]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[159]  H. Brooks,et al.  Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic. , 2007, Toxicology and applied pharmacology.

[160]  C. Ferreccio,et al.  Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. , 2007, Journal of the National Cancer Institute.

[161]  J. Eisenbart,et al.  The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production , 2007, The Journal of cell biology.

[162]  S. Morris Arginine metabolism: boundaries of our knowledge. , 2007, The Journal of nutrition.

[163]  M. Smyth,et al.  Immune surveillance of tumors. , 2007, The Journal of clinical investigation.

[164]  M. Esteller Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[165]  D. Haber,et al.  Cancer: Drivers and passengers , 2007, Nature.

[166]  Ruthann A Rudel,et al.  Environmental Factors in Breast Cancer Supplement to Cancer Chemicals Causing Mammary Gland Tumors in Animals Signal New Directions for Epidemiology , Chemicals Testing , and Risk Assessment for Breast Cancer Prevention , 2007 .

[167]  M. Srinivasulu,et al.  Overexpression of aldose reductase in human cancer tissues. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[168]  Lilia Alberghina,et al.  Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts. , 2006, Biochimica et biophysica acta.

[169]  N. Hay,et al.  Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt , 2006, Oncogene.

[170]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[171]  E. Blackburn,et al.  Genes and pathways downstream of telomerase in melanoma metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[172]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[173]  S. Fenton Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. , 2006, Endocrinology.

[174]  M. Dizdaroglu,et al.  Structural Alterations in Breast Stromal and Epithelial DNA: The Influence of 8,5-cyclo-2-Deoxyadenosine , 2006, Cell cycle.

[175]  G. Lenoir,et al.  Acetyl-CoA Carboxylase α Is Essential to Breast Cancer Cell Survival , 2006 .

[176]  J. Stone,et al.  Hydrogen peroxide: a signaling messenger. , 2006, Antioxidants & redox signaling.

[177]  K. Fisher,et al.  Each lipase has a unique sensitivity profile for organophosphorus inhibitors. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[178]  D. Wallace A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[179]  L. Nutt,et al.  Metabolic Regulation of Oocyte Cell Death through the CaMKII-Mediated Phosphorylation of Caspase-2 , 2005, Cell.

[180]  Daniel E Bauer,et al.  ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.

[181]  C. Wild Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology , 2005, Cancer Epidemiology Biomarkers & Prevention.

[182]  T. Kirchhausen,et al.  An emergency response team for membrane repair , 2005, Nature Reviews Molecular Cell Biology.

[183]  Russell G. Jones,et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.

[184]  S. Schreiber,et al.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[185]  N. Hay,et al.  Mitochondrial Hexokinases: Guardians of the Mitochondria , 2005, Cell cycle.

[186]  J. Beechem,et al.  Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line. , 2005, The Biochemical journal.

[187]  R. Robergs,et al.  Biochemistry of exercise-induced metabolic acidosis. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[188]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[189]  R. Robey,et al.  Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance. , 2004, American journal of physiology. Cell physiology.

[190]  K. Hellström,et al.  Development of a cancer DNA phenotype prior to tumor formation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[191]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[192]  Mohammad Abdollahi,et al.  Pesticides and oxidative stress: a review. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[193]  D. Kell Metabolomics and systems biology: making sense of the soup. , 2004, Current opinion in microbiology.

[194]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[195]  John Eric Wilson Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function , 2003, Journal of Experimental Biology.

[196]  R. Printz,et al.  Control of glucose phosphorylation in L6 myotubes by compartmentalization, hexokinase, and glucose transport. , 2003, The Biochemical journal.

[197]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[198]  B. Horecker The Pentose Phosphate Pathway , 2002, The Journal of Biological Chemistry.

[199]  I. Fidler,et al.  The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.

[200]  S. Kalhan,et al.  The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function* , 2002, Journal of Biological Chemistry.

[201]  C. Laboisse,et al.  Metabolic control of resistance of human epithelial cells to H2O2 and NO stresses. , 2002, The Biochemical journal.

[202]  Marc Dellian,et al.  Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[203]  E. Hiyama,et al.  Clinical utility of telomerase in cancer , 2002, Oncogene.

[204]  G. Filomeni,et al.  Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[205]  D. Weisenburger,et al.  Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States) , 2001, Cancer Causes & Control.

[206]  W. Zwerschke,et al.  Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex. , 2001, The Biochemical journal.

[207]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[208]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[209]  D. Hardie Metabolic control: A new solution to an old problem , 2000, Current Biology.

[210]  D. Carling,et al.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.

[211]  N. Chandel,et al.  Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.

[212]  C. Groussard,et al.  Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. , 2000, Journal of applied physiology.

[213]  K. Jeon,et al.  Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase1 , 2000, Journal of Immunology.

[214]  K. Pfeiffer,et al.  Supercomplexes in the respiratory chains of yeast and mammalian mitochondria , 2000, The EMBO journal.

[215]  K. Jeon,et al.  Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. , 2000, Journal of immunology.

[216]  E. Krebs,et al.  Protein phosphorylation and signal transduction. , 1999, Pharmacology & therapeutics.

[217]  D. Bhatnagar,et al.  Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species. , 1999, Toxicology letters.

[218]  G. Semenza,et al.  Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.

[219]  I. Tannock,et al.  The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. , 1998, British Journal of Cancer.

[220]  D. Davis,et al.  Workshop on hormones, hormone metabolism, the environment, and breast cancer. , 1998, Journal of the National Cancer Institute.

[221]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[222]  Karl Brand,et al.  Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[223]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[224]  J. Wilson An introduction to the isoenzymes of mammalian hexokinase types I-III. , 1997, Biochemical Society transactions.

[225]  A. Schwartz,et al.  Mechanism of Cancer Preventive Action of DHEA , 1995, Annals of the New York Academy of Sciences.

[226]  G. Sridevi,et al.  Cypermethrin-induced in vivo alterations in the carbohydrate metabolism of freshwater fish, Labeo rohita. , 1995, Ecotoxicology and environmental safety.

[227]  E H Holmes,et al.  The etiology and prediction of breast cancer. Fourier transform‐infrared spectroscopy reveals progressive alterations in breast DNA leading to a cancer‐like phenotype in a high proportion of normal women , 1995, Cancer.

[228]  P. Calder,et al.  The regulatory, informational, and immunomodulatory roles of fat fuels. , 1993, The American journal of clinical nutrition.

[229]  I. Tannock,et al.  Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[230]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[231]  L. Janiszewski The action of toxins on the voltage-gated sodium channel. , 1990, Polish journal of pharmacology and pharmacy.

[232]  B. Ames,et al.  Nature's chemicals and synthetic chemicals: comparative toxicology. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[233]  M. Lawrence,et al.  Effect of structural variations of non‐ionic surfactants on surface properties: surfactants with semi‐polar hydrophobes , 1990, The Journal of pharmacy and pharmacology.

[234]  C. Nathan,et al.  Secretion of pyruvate. An antioxidant defense of mammalian cells , 1987, The Journal of experimental medicine.

[235]  A. Pegg Recent advances in the biochemistry of polyamines in eukaryotes. , 1986, The Biochemical journal.

[236]  B Crabtree,et al.  The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells , 1985, Bioscience reports.

[237]  I. Selikoff Lessons for living in a chemical world , 1984, Bulletin of Environmental Contamination and Toxicology.

[238]  E. Newsholme,et al.  Biochemistry for the Medical Sciences , 1983 .

[239]  J. H. Johnson,et al.  The role of ATPase in glycolysis of Ehrlich ascites tumor cells. , 1983, The Journal of biological chemistry.

[240]  I. Arany,et al.  Effect of carcinogenic and non-carcinogenic chemicals on the activities of four glycolytic enzymes in mouse lung. , 1980, Chemico-biological interactions.

[241]  R. Hicks,et al.  Proceedings: Syncarcinogenesis with n-methyl N-nitrosourea (MNU) and cyclamate in rat urinary bladder. , 1974, British Journal of Cancer.

[242]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[243]  O. Warburg,et al.  [Genesis of tumor metabolism by vitamin B1 deficiency (thiamine deficiency)]. , 1970, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete.

[244]  G. M. Walton,et al.  Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. , 1967, The Journal of biological chemistry.

[245]  D. E. Atkinson,et al.  Biological feedback control at the molecular level. , 1965, Science.

[246]  K. Ibsen The Crabtree effect: a review. , 1961, Cancer research.

[247]  O. Warburg,et al.  Partielle Anaerobiose und Strahlenempfindlichkeit der Krebszellen , 1958 .

[248]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. XIII. Substrate competition in fatty acid oxidation in ascites tumor cells. , 1958, Cancer research.

[249]  R. K. Kielley Inhibitory effect of some aminoazo dyes and other carcinogens on glutamate oxidation in mitochondria of riboflavine-deficient rat liver. , 1957, Journal of the National Cancer Institute.

[250]  O. Warburg On respiratory impairment in cancer cells. , 1956, Science.

[251]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[252]  H. Goldblatt,et al.  INDUCED MALIGNANCY IN CELLS FROM RAT MYOCARDIUM SUBJECTED TO INTERMITTENT ANAEROBIOSIS DURING LONG PROPAGATION IN VITRO , 1953, The Journal of experimental medicine.

[253]  O. Meyerhof Mechanisms of glycolysis and fermentation. , 1951, Canadian journal of medical sciences.

[254]  P. Taylor Role of amino acid transporters in amino acid sensing. , 2014, The American journal of clinical nutrition.

[255]  J. Lubin,et al.  Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study. , 2013, American journal of epidemiology.

[256]  Robert J Kavlock,et al.  In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[257]  Christian M. Metallo,et al.  Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth , 2013 .

[258]  Songfang Wu,et al.  Dual roles of PKM2 in cancer metabolism. , 2013, Acta biochimica et biophysica Sinica.

[259]  Christian M. Metallo,et al.  Metabolic pathway alterations that support cell proliferation. , 2011, Cold Spring Harbor symposia on quantitative biology.

[260]  J. Brugge,et al.  Extracellular matrix regulation of metabolism and implications for tumorigenesis. , 2011, Cold Spring Harbor symposia on quantitative biology.

[261]  C. Dang,et al.  Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. , 2011, Cold Spring Harbor symposia on quantitative biology.

[262]  T. Tsuruo,et al.  De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.

[263]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[264]  S. Weinhouse,et al.  The Warburg hypothesis fifty years later , 2004, Zeitschrift für Krebsforschung und Klinische Onkologie.

[265]  D. Brdiczka,et al.  The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. , 2003, Acta biochimica Polonica.

[266]  G. Hart,et al.  Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. , 1997, Annual review of biochemistry.

[267]  H. Herz,et al.  Multicomponent investigations of the hydrogen peroxide- and hydroxyl radical-scavenging antioxidant capacities of biofluids: the roles of endogenous pyruvate and lactate. Relevance to inflammatory joint diseases. , 1997, Free radical research.

[268]  L. Weiss Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells. , 1996, Cancer treatment and research.

[269]  R. Hebbel,et al.  alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. , 1995, The American journal of physiology.

[270]  M. Fischereder,et al.  Effect of pyruvate on oxidant injury to isolated and cellular DNA. , 1994, Kidney international.

[271]  L. Hue,et al.  Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. , 1993, Advances in enzyme regulation.

[272]  E. Newsholme,et al.  Application of metabolic-control logic to fuel utilization and its significance in tumor cells. , 1991, Advances in enzyme regulation.

[273]  P. Srere,et al.  Complexes of sequential metabolic enzymes. , 1987, Annual review of biochemistry.

[274]  D. Oxender,et al.  Mechanisms of transport of amino acids across membranes. , 1987, Annual review of nutrition.

[275]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[276]  R. Hicks Multistage carcinogenesis in the urinary bladder. , 1980, British medical bulletin.

[277]  E. Racker A new look at mechanisms in bioenergetics , 1976 .

[278]  Horecker Bl The biochemistry of sugars. , 1976 .

[279]  H A KREBS,et al.  Regulation of Metabolism , 1968 .

[280]  O. H. Lowry,et al.  THE RELATIONSHIPS BETWEEN SUBSTRATES AND ENZYMES OF GLYCOLYSIS IN BRAIN. , 1964, The Journal of biological chemistry.

[281]  A. Aisenberg The glycolysis and respiration of tumors , 1961 .

[282]  Henderson Jf,et al.  Biochemistry of tumors. , 1960 .

[283]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. III. Diphosphopyridine nucleotide requirements for oxidations by mitochondria of neoplastic and non-neoplastic tissues. , 1953, Cancer research.

[284]  F. Dickens,et al.  Metabolism of normal and tumour tissue: Ammonia and urea formation. , 1933, The Biochemical journal.

[285]  F. Dickens,et al.  The metabolism of normal and tumour tissue: The effects of lactate, pyruvate and deprivation of substrate. , 1933, The Biochemical journal.

[286]  F. Dickens,et al.  The metabolism of normal and tumour tissue: The respiratory quotient, and the relationship of respiration to glycolysis. , 1930, The Biochemical journal.

[287]  H G Crabtree,et al.  Observations on the carbohydrate metabolism of tumours. , 1929, The Biochemical journal.